Dr James Dromey

James is Chief Operating Officer at the Murdoch Childrens Research Institute (MCRI), one of Australia’s largest research institutes with close to 2,000 researchers working across all areas of child and adolescent health.

Prior to this, he was General Manager – Business Development & Strategy at MCRI, where he led the development and commercialisation of a pipeline of more than 400 research projects on new drugs, devices, diagnostics and digital health technologies.

James championed the Murdoch Childrens’ drive into digital health and has positioned the Institute as an international leader in this area. He led the development and implementation of a new model in medical research that facilitates greater collaboration and knowledge transfer across health and technology, engineering and ICT sectors.

James has over 17 years’ experience in health and medical research, both as a research scientist and in technology innovation and commercialisation. Previously, James was Business Development Manager at the Walter & Eliza Hall Institute in Melbourne, where he led a number of strategic collaborations with industry partners ranging from SMEs, to top five international pharmaceutical and Fortune 500 companies. As a research scientist, he was part of a team that developed a first-in-class vaccine for celiac disease that went on to raise over $35 million and is now in clinical trials. His work has resulted in the filing of three patent applications, two of which have been commercialised. James is currently a Non-Executive Director of GI Therapies, an unlisted spin-out from the Murdoch Childrens.